CL
ABBV icon

COWA LLC’s AbbVie ABBV Stock Holding History

COWA LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
5,469
-361
-6% -$77.7K 0.35% 46
2026
Q1 		$1.27M Sell
5,830
-335
-5% -$74.3K 0.34% 46
2025
Q4 		$1.41M Buy
6,165
+1,018
+20% +$232K 0.43% 39
2025
Q3 		$1.19M Sell
5,147
-139
-3% -$28.3K 0.4% 45
2025
Q2 		$981K Buy
5,286
+329
+7% +$61.1K 0.37% 49
2025
Q1 		$1.04M Sell
4,957
-500
-9% -$97.2K 0.44% 46
2024
Q4 		$970K Hold
5,457
– – 0.45% 46
2024
Q3 		$1.08M Hold
5,457
– – 0.51% 44
2024
Q2 		$936K Hold
5,457
– – 0.5% 41
2024
Q1 		$994K Sell
5,457
-200
-4% -$34.5K 0.59% 36
2023
Q4 		$877K Sell
5,657
-200
-3% -$29.2K 0.55% 36
2023
Q3 		$873K Sell
5,857
-200
-3% -$29.4K 0.59% 34
2023
Q2 		$816K Buy
6,057
+200
+3% +$29.3K 0.54% 36
2023
Q1 		$933K Sell
5,857
-200
-3% -$30.6K 0.76% 30
2022
Q4 		$979K Hold
6,057
– – 0.61% 33
2022
Q3 		$813K Sell
6,057
-403
-6% -$57.8K 0.54% 39
2022
Q2 		$989K Sell
6,460
-182
-3% -$27.8K 0.57% 40
2022
Q1 		$1.08M Sell
6,642
-292
-4% -$42.4K 0.53% 39
2021
Q4 		$939K Sell
6,934
-223
-3% -$26.3K 0.47% 42
2021
Q3 		$772K Sell
7,157
-108
-1% -$12.3K 0.44% 46
2021
Q2 		$830K Sell
7,265
-99
-1% -$11.2K 0.52% 38
2021
Q1 		$792K Buy
7,364
+1,140
+18% +$122K 0.48% 41
2020
Q4 		$698K Buy
+6,224
New +$598K 0.53% 42

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

COWA LLC's ABBV Position: Q2 2026 in Review

COWA LLC reduced its AbbVie (ABBV) stake by 6.2% in Q2 2026, selling an estimated $77.7K and leaving 5,469 shares worth $1.38M. The position accounts for 0.35% of the portfolio, ranked #46.

COWA LLC first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.41M in Q4 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • COWA LLC held 5,469 shares of AbbVie worth $1.38M as of Q2 2026.
  • COWA LLC sold 361 AbbVie shares in Q2 2026, an estimated $77.7K.
  • AbbVie made up 0.35% of COWA LLC's portfolio in Q2 2026, its #46 holding.
  • COWA LLC first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • COWA LLC's AbbVie position peaked at $1.41M in Q4 2025.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on COWA LLC's 13F filing for Q2 2026, filed 6 Aug 2026.